Toward the use of buprenorphine in infants for neonatal opioid withdrawal syndrome: summary of an NIH workshop.

Simon, Alan E; Freund, Michelle P; Archer, Stephanie Wilson; Bremer, Andrew A

Simon, Alan E; Freund, Michelle P; Archer, Stephanie Wilson; Bremer, Andrew A.

Simon AE; Office of the Director, National Institutes of Health, Bethesda, MD, 20892, USA.
Freund MP; National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, 20892, USA.
Archer SW; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892, USA.
Bremer AA; Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, 20892, USA. andrew.bremer@nih.gov.

J Perinatol ; 41(6): 1213-1215, 2021 06.

Article in English | MEDLINE | ID: covidwho-1550271

Subject(s)

Buprenorphine; Infant, Newborn, Diseases; Neonatal Abstinence Syndrome; Analgesics, Opioid/adverse effects; Humans; Infant; Infant, Newborn; Neonatal Abstinence Syndrome/drug therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Buprenorphine / Neonatal Abstinence Syndrome / Infant, Newborn, Diseases Limits: Humans / Infant / Infant, Newborn Language: English Journal: J Perinatol Journal subject: Perinatology Year: 2021 Document Type: Article Affiliation country: S41372-020-00886-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google